VERU logo

Veru Inc.


VERU: Veru Inc is a biopharmaceutical company with a drug development program for the treatment of hospitalized COVID-19 patients at high risk for acute respiratory distress syndrome (ARDS) and other viral-related ARDS and for the management of breast and prostate cancers, as well as a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA and others where in maximum revenue is generated from USA.


Show VERU Financials

Consumer Interest
SEC Filings

Recent trades of VERU by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by VERU's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Methods of treating coronavirus May. 16, 2023

Number of mentions of VERU in WallStreetBets Daily Discussion


Recent insights relating to VERU

CNBC Recommendations

Recent picks made for VERU stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in VERU

Corporate Flights

Flights by private jets registered to VERU